Cargando…
Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor–Based Antiretroviral Therapy in India
Background. Our aim was to study the incidence and pattern of dyslipidemia among human immunodeficiency virus (HIV)–infected patients with tuberculosis (TB) who received once-daily antiretroviral therapy (ART). Methods. Antiretroviral-naive HIV-infected patients with TB were recruited to a trial of...
Autores principales: | Padmapriyadarsini, Chandrasekaran, Ramesh Kumar, S., Terrin, Norma, Narendran, Gopalan, Menon, Pradeep A., Ramachandran, Geetha, Subramanyan, Sudha, Venkatesan, Perumal, Wanke, Christine, Swaminathan, Soumya |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3060904/ https://www.ncbi.nlm.nih.gov/pubmed/21252141 http://dx.doi.org/10.1093/cid/ciq195 |
Ejemplares similares
-
Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?
por: Gupta, Soham, et al.
Publicado: (2016) -
Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials
por: Nachega, Jean B., et al.
Publicado: (2014) -
An Advanced AIDS Patient With CD4 <20 and Plasmablastic Lymphoma Achieving Complete Response With the V-EPOCH Regimen
por: Nelson, Blessie, et al.
Publicado: (2020) -
Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa
por: Matthews, Lynn T, et al.
Publicado: (2019) -
Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis
por: Gopalan, Narendran, et al.
Publicado: (2016)